AFP and neoplasm: Sequentially, by using the ratios of BETAs between other prognostic factors and tumor burden 3, 7.7 (calculated as 0.823 divided by 1.064 and timed 10), 4.2, 5.6, 3.2, 5.8, 3.4 points were assigned to patients who were CTP class C, CTP class B, tumor burden 2, hepatitis B, PS 3–4 and AFP ≥ 400 ng/mL, respectively.